IP Verse

Generics Uk competitive analysis

Explore the latest publications and patents granted to Generics Uk, showcasing their recent innovations and technological advancements.

Last updated on: Sep 25, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Generics Uk
EP2280929	Jan 31, 2018	An Improved Process For The Preparation Of Amines	No Opposition Filed Within Time Limit

Explore patent oppositions filed by Generics Uk against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3689365	Use Of Long-Acting Glp-1 Peptides	NOVO NORDISK	Aug 7, 2025
EP4070800	Cladribine Regimen For Treating Multiple Sclerosis	MERCK SERONO	Jul 16, 2025
EP4125903	Methods For Dose Initiation Of Aripiprazole Treatments	OTSUKA PHARMACEUTICAL	Jul 9, 2025
EP4321157	New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)	NOVARTIS	Jul 1, 2025
EP3897582	Process Of Spray Drying Of Glp-1 Peptide	NOVO NORDISK	Jun 11, 2025
EP4065119	Methods Of Treating Pulmonary Arterial Hypertension	ACTELION PHARMACEUTICALS	Jun 4, 2025
EP3923943	Genotype And Dose-Dependent Response To An Asbti In Patients With Bile Salt Export Pump Deficiency	MIRUM PHARMACEUTICALS	Apr 30, 2025
EP4054620	Glp-1 Receptor Agonists In Dementia	NOVO NORDISK	Feb 27, 2025
EP3897646	Pharmaceutical Composition For The Treatment Of Pulmonary Arterial Hypertension	ACTELION PHARMACEUTICALS	Feb 21, 2025
EP4041186	An Anhydrous Pharmaceutical Composition For Maintenance Treatment Of Psoriasis	LEO PHARMA	Feb 21, 2025

Discover the latest PTAB cases involving Generics Uk, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Generics Uk with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
GENERICS UK TRADING MYLAN	13	-	-	-	Highly Aggressive
ALCON RESEARCH	-	14	1	8	Defensive
NOVARTIS	6	406	-	21	Defensive
YEDA RESEARCH	-	21	-	9	Non-Active